B Cell Recognition of the Conserved HIV-1 Co-Receptor Binding Site Is Altered by Endogenous Primate CD4

被引:57
作者
Forsell, Mattias N. E. [1 ,2 ,3 ]
Dey, Barna [1 ]
Moerner, Andreas [3 ]
Svehla, Krisha [1 ]
O'dell, Sijy [1 ]
Hoegerkorp, Carl-Magnus [1 ]
Voss, Gerald [4 ]
Thorstensson, Rigmor [3 ]
Shaw, George M. [5 ]
Mascola, John R. [1 ]
Hedestam, Gunilla B. Karlsson [2 ,3 ]
Wyatt, Richard T. [1 ]
机构
[1] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA
[2] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden
[3] Swedish Inst Infect Dis Control, Solna, Sweden
[4] GlaxoSmithKline Biol, Rixensart, Belgium
[5] Univ Alabama, Birmingham, AL USA
关键词
D O I
10.1371/journal.ppat.1000171
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The surface HIV-1 exterior envelope glycoprotein, gp120, binds to CD4 on the target cell surface to induce the coreceptor binding site on gp120 as the initial step in the entry process. The binding site is comprised of a highly conserved region on the gp120 core, as well as elements of the third variable region (V3). Antibodies against the co-receptor binding site are abundantly elicited during natural infection of humans, but the mechanism of elicitation has remained undefined. In this study, we investigate the requirements for elicitation of co-receptor binding site antibodies by inoculating rabbits, monkeys and human-CD4 transgenic (huCD4) rabbits with envelope glycoprotein (Env) trimers possessing high affinity for primate CD4. A cross-species comparison of the antibody responses showed that similar HIV-1 neutralization breadth was elicited by Env trimers in monkeys relative to wild-type (WT) rabbits. In contrast, antibodies against the co-receptor site on gp120 were elicited only in monkeys and huCD4 rabbits, but not in the WT rabbits. This was supported by the detection of high-titer co-receptor antibodies in all sera from a set derived from human volunteers inoculated with recombinant gp120. These findings strongly suggest that complexes between Env and (high-affinity) primate CD4 formed in vivo are responsible for the elicitation of the co-receptor-site-directed antibodies. They also imply that the naive B cell receptor repertoire does not recognize the gp120 co-receptor site in the absence of CD4 and illustrate that conformational stabilization, imparted by primary receptor interaction, can alter the immunogenicity of a type 1 viral membrane protein.
引用
收藏
页数:12
相关论文
共 41 条
  • [1] A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure
    Binley, JM
    Sanders, RW
    Clas, B
    Schuelke, N
    Master, A
    Guo, Y
    Kajumo, F
    Anselma, DJ
    Maddon, PJ
    Olson, WC
    Moore, JP
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (02) : 627 - 643
  • [2] Structure of an unliganded simian immunodeficiency virus gp120 core
    Chen, B
    Vogan, EM
    Gong, HY
    Skehel, JJ
    Wiley, DC
    Harrison, SC
    [J]. NATURE, 2005, 433 (7028) : 834 - 841
  • [3] The structural biology of type I viral membrane fusion
    Colman, PM
    Lawrence, MC
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (04) : 309 - 319
  • [4] A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120
    Crooks, Emma T.
    Moore, Penny L.
    Franti, Michael
    Cayanan, Charmagne S.
    Zhu, Ping
    Jiang, Pengfei
    de Vries, Robbert P.
    Wiley, Cheryl
    Zharkikh, Irina
    Schuelke, Norbert
    Roux, Kenneth H.
    Montefiori, David C.
    Burton, Dennis R.
    Binley, James M.
    [J]. VIROLOGY, 2007, 366 (02) : 245 - 262
  • [5] Antigenic conservation and immunogenicity of the HIV coreceptor binding site
    Decker, JM
    Bibollet-Ruche, F
    Wei, XP
    Wang, SY
    Levy, DN
    Wang, WQ
    Delaporte, E
    Peeters, M
    Derdeyn, CA
    Allen, S
    Hunter, E
    Saag, MS
    Hoxie, JA
    Hahn, BH
    Kwong, PD
    Robinson, JE
    Shaw, GM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) : 1407 - 1419
  • [6] Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens
    DeVico, Anthony
    Fouts, Timothy
    Lewis, George K.
    Gallo, Robert C.
    Godfrey, Karla
    Charurat, Manhattan
    Harris, Ilia
    Galmin, Lindsey
    Pal, Ranajit
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (44) : 17477 - 17482
  • [7] Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: Antigenicity, biophysics, and immunogenicity
    Dey, Barna
    Pancera, Marie
    Svehla, Krisha
    Shu, Yuuei
    Xiang, Shi-Hua
    Vainshtein, Jeffrey
    Li, Yuxing
    Sodroski, Joseph
    Kwong, Peter D.
    Mascola, John R.
    Wyatt, Richard
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (11) : 5579 - 5593
  • [8] Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry
    Farzan, M
    Mirzabekov, T
    Kolchinsky, P
    Wyatt, R
    Cayabyab, M
    Gerard, NP
    Gerard, C
    Sodroski, J
    Choe, H
    [J]. CELL, 1999, 96 (05) : 667 - 676
  • [9] Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
    Fernando, Kathy
    Hu, Haitao
    Ni, Houping
    Hoxie, James A.
    Weissman, Drew
    [J]. BLOOD, 2007, 109 (06) : 2538 - 2544
  • [10] FURUKAWA S, 1991, CLIN EXP IMMUNOL, V86, P134